COLUMBUS, IN (December 9, 2019) – Grammer Industries, Inc., (“Grammer” or the “Company”) an Indiana-based hazardous materials transportation and logistics […]
NEW HAVEN, Conn., Nov. 13, 2019 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on
New York and London, October 25, 2019 –Stellex Capital Management (“Stellex”), a middle market private equity firm with offices in
New York and London, October 25, 2019 –Stellex Capital Management (“Stellex”), a middle market private equity firm with offices in
Transaction expected to close in 4Q 2019 New York and London, September 12, 2019 –Stellex Capital Management(“Stellex”), a
Advancement of Nalbuphine ER Through Clinical Development in Multiple Indications New Haven, CT, August 12, 2019– Trevi Therapeutics, Inc. (Nasdaq:
